2.6
Malattia di Graves II: Fisiopatologia
La malattia di Graves è una malattia autoimmune caratterizzata dalla produzione di immunoglobuline stimolanti della tiroide (TSI) che attivano i recet…
La malattia di Graves inizia quando il sistema immunitario non riesce a mantenere la tolleranza, permettendo alle cellule plasmatiche di produrre e rilasciare immunoglobuline stimolanti della tiroide, o TSI.
Questi anticorpi si legano ai recettori ormonali stimolanti della tiroide, o TSH-R, sulle cellule follicolari tiroidee e imitano l'azione dell'ormone stimolante della tiroide, o TSH.
Con i recettori continuamente sovrastimolati dagli anticorpi, la ghiandola tiroidea produce e rilascia grandi quantità di tiroxina o T4 e triiodotironina o T3 senza un normale controllo regolatore.
Microscopicamente, le cellule follicolari diventano alte e affollate, la vascolarità aumenta e le riserve colloidi si esauriscono rapidamente, lasciando bordi ondulati.
La stessa risposta immunitaria colpisce i fibroblasti che esprimono recettori TSH nell'orbita e nella pelle.
Provoca gonfiore intorno agli occhi, noto come edema periorbitale, protrusione degli occhi chiamata esoftalmo e ispessimento delle chiazze sulle tibie, note come mixedema pretibiale.
L'eccesso di T4 e T3 nel sangue aumenta il metabolismo, aumentando la produzione di calore e la frequenza cardiaca.
View the full transcript and gain access to JoVE Core videos
Q1: How do thyroid-stimulating immunoglobulins cause Graves' disease?
In Graves' disease, thyroid-stimulating immunoglobulins (TSI) are autoantibodies produced when immune tolerance fails. These antibodies bind to TSH receptors on thyroid follicular cells and mimic thyroid-stimulating hormone, continuously overstimulating the receptors. This bypasses normal feedback control, causing excessive production and release of T4 and T3 without regulation.
Q2: What microscopic changes occur in thyroid follicular cells during Graves' disease?
Thyroid follicular cells become tall and columnar, increase in number, and crowd together. Vascularity increases significantly throughout the gland. Colloid stores are rapidly depleted due to excessive hormone utilization, leaving characteristic wavy or scalloped edges on the follicles.
Q3: Why does Graves' disease cause eye protrusion and orbital swelling?
The same autoimmune response targeting thyroid cells also affects fibroblasts expressing TSH receptors in the orbit. Glycosaminoglycan deposition in orbital fibroblasts causes edema and tissue swelling, leading to periorbital edema and exophthalmos, or eye protrusion. This extrathyroidal manifestation occurs independently of thyroid hormone levels.
Q4: What is pretibial myxedema and how does it develop in Graves' disease?
Pretibial myxedema is thickened, swollen skin patches appearing on the shins. It develops when the autoimmune response targets TSH receptors on skin fibroblasts, particularly in the pretibial region. Glycosaminoglycan accumulation in these fibroblasts causes localized edema and tissue thickening characteristic of this condition.
Q5: How do elevated thyroid hormones affect metabolic rate and heart function in Graves' disease?
Excess T4 and T3 in the blood increase basal metabolic rate and heat production. Elevated thyroid hormones also increase sensitivity to catecholamines, raising heart rate and cardiac output. This hypermetabolic state produces tachycardia, palpitations, heat intolerance, and increased sweating as patients struggle to dissipate excess metabolic heat.
Q6: Why does negative feedback control fail to suppress thyroid hormone production in Graves' disease?
Although elevated T3 and T4 normally suppress pituitary TSH through negative feedback, this regulatory mechanism fails in Graves' disease. Antibody-mediated stimulation of TSH receptors persists independently of TSH levels, continuously driving thyroid hormone synthesis. The immune attack bypasses the normal hypothalamic-pituitary-thyroid axis control.
Q7: What systemic symptoms result from the hypermetabolic state in Graves' disease?
The hypermetabolic state produces weight loss despite increased appetite, fine tremors, anxiety, and hyperactivity. Patients experience tachycardia, palpitations, muscle weakness, and heat intolerance with excessive sweating. In severe cases, arrhythmias or thyroid storm may develop, representing life-threatening complications of uncontrolled hyperthyroidism.